|
PF-46391 |
ESCITALOPRAM Normon 10mg Comprimidos recubiertos con pelicula EFG |
2016-09-21 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Internacional |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46482 |
ESCITALOPRAM Normon 20 mg comprimido recubierto con película EFG |
2016-10-03 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Drogueria Internacional Sociedad Anonima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46801 |
ARTICAINA CON EPINEFRINA Normon 40/0.01mg /mL Solución Inyectable EFG |
2022-01-09 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Internacional |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46737 |
GABAPENTINA Normon 400 mg Cápsulas Duras EFG |
2026-05-31 |
|
Laboratorios Normon S.A. |
España
|
Asistencia Respiratoria |
Iberfarma |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46600 |
GABAPENTINA Normon 300 mg Cápsulas Duras EFG |
2027-01-21 |
|
Laboratorios Normon S.A. |
España
|
Asistencia Respiratoria |
Iberfarma |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46524 |
PANTOPRAZOL Normon 40 mg Polvo para Solución Inyectable EFG |
2021-10-13 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Farmacias Del Ahorro Reu Central |
Internacional |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46592 |
ACECLOFENACO Normon 100 mg Comprimido recubierto con película EFG |
2016-10-28 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Internacional |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46816 |
ARTICAINA CON EPINEFRINA Normon 40/0.005 mg/mL Solución Inyectable EFG |
2022-01-17 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Internacional |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46974 |
PANTOPRAZOL Normon 40 mg Comprimidos gastrorresistentes EFG |
2027-05-18 |
|
Laboratorios Normon S.A. |
España
|
Asistencia Respiratoria |
Iberfarma |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48982 |
LAMOTRIGINA Normon 25 mg Comprimidos dispersables/masticables EFG |
2018-08-09 |
|
Laboratorios Normon S.A. |
España
|
Ladi |
Amicelco |
Drogueria Internacional Sociedad Anonima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|